about
Bacterial infections in cirrhosis: A critical review and practical guidanceImmunomodulating effects of antibiotics used in the prophylaxis of bacterial infections in advanced cirrhosisIntensive care management of patients with liver disease: proceedings of a single-topic conference sponsored by the Brazilian Society of HepatologySpontaneous bacterial peritonitis: The clinical challenge of a leaky gut and a cirrhotic liverBeta-blockers in liver cirrhosisCirrhosis and its complications: evidence based treatment.New determinants of prognosis in bacterial infections in cirrhosis.Third-generation cephalosporin-resistant spontaneous bacterial peritonitis: a single-centre experience and summary of existing studies.Zero tolerance for healthcare-associated MRSA bacteraemia: is it realistic?Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites.Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosisMeasurement of serum procalcitonin levels for the early diagnosis of spontaneous bacterial peritonitis in patients with decompensated liver cirrhosis.Appropriate empirical antibiotic use and 30-d mortality in cirrhotic patients with bacteremia.Mean platelet volume as a novel predictor of systemic inflammatory response in cirrhotic patients with culture-negative neutrocytic ascites.Multiresistant bacterial infections in liver cirrhosis: Clinical impact and new empirical antibiotic treatment policies.Role of human albumin in the management of complications of liver cirrhosis.The usefulness of C-reactive protein and neutrophil-to-lymphocyte ratio for predicting the outcome in hospitalized patients with liver cirrhosisSerum interleukin-6 in the diagnosis of bacterial infection in cirrhotic patients: A meta-analysisLiver injury in the elderly due to fluoroquinolones: should these drugs be avoided?Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis.Diagnosis and management of bacterial infections in decompensated cirrhosis.Bacterial infections in end-stage liver disease: current challenges and future directionsCirrhosis is Associated with an Increased 30-Day Mortality After Venous Thromboembolism.Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia.Bloodstream infections in patients with liver cirrhosis.PREVALENCE OF BACTERIAL RESISTANCE IN HOSPITALIZED CIRRHOTIC PATIENTS IN SOUTHERN BRAZIL: A NEW CHALLENGE.The role of serum procalcitonin levels in predicting ascitic fluid infection in hospitalized cirrhotic and non-cirrhotic patientsNovel prevention strategies for bacterial infections in cirrhosis.Interaction between periodontitis and liver diseasesUse of the delta neutrophil index as a prognostic factor of mortality in patients with spontaneous bacterial peritonitis: implications of a simple and useful marker.Immune function biomarker QuantiFERON-monitor is associated with infection risk in cirrhotic patients.Pseudo-outbreak of Klebsiella oxytoca spontaneous bacterial peritonitis attributed to contamination of multidose vials of culture medium supplement.Hypoalbuminemia.The endocannabinoid system in advanced liver cirrhosis: pathophysiological implication and future perspectives.Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspectsNovel insights in preventing Gram-negative bacterial infection in cirrhotic patients: review on the effects of GM-CSF in maintaining homeostasis of the immune system.Complications of cirrhosis. A 50 years flashback.Cirrhotic Multiorgan Syndrome.Clostridium difficile infection in patients with liver disease: a review.New antibiotic strategies in patients with cirrhosis and bacterial infection.
P2860
Q26766663-64A6D02A-982D-48B4-A0C9-3D1071E93866Q26778064-28264377-8428-432A-A4ED-410D16AA00F9Q26865028-66C4B00A-13E9-4B01-B1D1-AED955444BC8Q27001540-D5CADAD6-7023-488D-9FC2-B09AD38DBDD5Q27012922-C24866A9-AF39-4793-8A7C-5765D8D8AD22Q33594931-8169FB7F-4C43-42C1-8B9D-A90A28F5C886Q33780129-DFBA481B-3769-42C3-B306-ECF46D923C43Q33810108-31C60D93-7F2D-42FE-A385-E56FF57015E0Q33910015-F38A0552-E692-4087-BB1C-722E2BB0B8AAQ34450128-16145DA0-2CBF-4AC2-8735-76807C73050DQ35079589-FD5D21BF-9F53-47B8-8404-659B09463DBAQ35096465-076BA7EE-95FB-43AB-94FC-11154E238C73Q35221810-D6CA9301-5E97-4A22-AAA2-028F8C3F5062Q35567734-D9662EEE-915E-4DE1-8346-D67277FF104EQ35567738-ED6C65D9-F93D-4AD7-B47F-2E0723FE9295Q35574320-B611AE14-78AC-4DBC-A80B-3AAA8FA66A14Q35820519-73D01F45-AD21-4BC6-AC77-C8BE6E27A010Q36163610-8F8A635F-4525-4ED8-AA2B-A8F0C34A10DDQ36315118-53151457-6131-4D54-B8C3-5C9C3365BEB5Q36472730-19724F53-C6E3-4275-BACC-679C35FC330CQ36582826-4820F28F-4DA8-41AC-8D3B-F0839E6B4A06Q36705999-BA6B4C23-D0FD-4313-A4C6-3E3103F4B015Q36752021-4E4304B1-F778-4D80-A0C3-37E3E17458C0Q36772620-0795897B-7168-42BA-B0C4-F1BDF9D6E92FQ36913304-6BB36836-4309-4870-AA84-94ABA01E8258Q36935021-77F90507-D856-49C8-BC02-8C17A2E556A4Q37119332-4DBD1FD0-B740-45A5-A490-67A5181497C9Q37183463-F3BDB5A2-1045-4811-AA55-A81B13FAB625Q37204278-5BF63799-1DD0-48B9-96E7-E86ACADF0229Q37510598-83E872B5-1142-460F-80A0-7A191F7A2E30Q37513107-4B5C1C17-DFCD-43AD-B2DF-4843EEC52E46Q37642972-932BB7A2-9B82-42C3-8E08-128D47A6D439Q38052843-76D4FFCD-6660-44C8-B064-710D5A7DE353Q38124458-B8E64723-ABF0-487D-83AB-CC37F08664D0Q38268612-D9CAC76B-79D5-4F3D-97CD-8B7DFBA968DAQ38383499-D42CAB0F-D29C-492B-9798-196EB31284F4Q38424360-A8F5BAFA-ED79-4A74-8487-B2045324D4BFQ38538183-B8E01338-F2AA-44BC-B8EE-4573D05D1A65Q38600142-9CAD3BDD-F77D-489D-8F30-D0AD69B4015AQ38606723-1C1AC5F2-F10A-4261-80B8-2692C0E01A15
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Management of bacterial infections in cirrhosis.
@en
Management of bacterial infections in cirrhosis.
@nl
type
label
Management of bacterial infections in cirrhosis.
@en
Management of bacterial infections in cirrhosis.
@nl
prefLabel
Management of bacterial infections in cirrhosis.
@en
Management of bacterial infections in cirrhosis.
@nl
P1476
Management of bacterial infections in cirrhosis
@en
P2093
Javier Fernández
P356
10.1016/S0168-8278(12)60002-6
P478
56 Suppl 1
P577
2012-01-01T00:00:00Z